Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples